Commonwealth Equity Services »

Inhibrx Biosciences shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $267k 2.8k 94.75

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Total Stk Mkt (VTI)
Capital Group Dividend Value Shs Creat Unit (CGDV)
Capital Group Growth Etf Shs Creat Unit (CGGR)

View all positions for Commonwealth Equity Services

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Viking Global Investors
Morgan Stanley
Sanofi
HighTower Advisors
BlackRock
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Capital Research Global Investors
Woodline Partners
Millennium Management
Partner Fund Management
Schonfeld Strategic Advisors
Geode Capital Management

View all funds holding Inhibrx Biosciences